Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2016

Feb 1, 2016

34519_dirs_2016-02-01_8b873096-8ee4-4858-a22f-331e9f40197a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2016-01-29

Reporting Person: ROTHSCHILD JONATHAN E (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-01-29 Common Stock, par value $0.10 per share P 4761.0000 $5.2500 Acquired 505397.0000 Direct
2016-01-29 Common Stock, par value $0.10 per share P 4761.0000 $5.2500 Acquired 510158.0000 Direct

Footnotes

F1: These shares were acquired by Arterio Inc., a corporation owned solely by Mr. Rothschild.

F2: This figure includes 226,416 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild.